hs-CRP were determined in 457 women: 123 with metabolic syndrome and 334 without metabolic syndrome. The correlation between d-ROMs and hs-CRP levels was compared between the two groups. RESULTS: The group with metabolic syndrome had significantly higher d-ROMs and hs-CRP levels than the group without metabolic syndrome. While the d-ROMs level was significantly and positively correlated with the hs-CRP level in both groups, the correlation level between the two groups was significantly different. Multiple linear regression analysis adjusted for other cardiometabolic risk factors also showed significant positive correlation between d-ROMs and hs-CRP levels in both groups. CONCLUSION: Subjects with metabolic syndrome may have a closer relationship between inflammation and oxidative stress than subjects without metabolic syndrome, possibly reflecting their increased predisposition to atherosclerosis. Further studies are necessary to confirm the observed relationship.
Introduction
Metabolic syndrome, which includes a cluster of cardiometabolic risk factors such as obesity, hypertension, hyperglycaemia and dyslipidaemia, is increasing in prevalence worldwide and is associated with the development of atherosclerosis and cardiovascular disease (CVD). 1, 2 Conceptually, chronic low-grade inflammation, as evaluated by the level of high-sensitivity C-reactive protein (hs-CRP), is regarded to be a crucial factor underlying the pathophysiology of atherosclerosis. 3, 4 Oxidative stress is also an important contributor to atherosclerosis. 5 Because inflammation and oxidative stress often coexist and since metabolic syndrome is considered to be an oxidative and inflammatory condition, 4 -6 patients with metabolic syndrome may display a closer association between K Kotani, N Sakane C-reactive protein and d-ROMs in metabolic syndrome inflammation and oxidative stress compared with those without metabolic syndrome.
While the association of inflammation and oxidative stress is assumed to predispose metabolic syndrome patients to atherosclerosis, there is little information available on the relationship between inflammation and oxidative stress from human clinical studies. 7, 8 For example, one study reported that metabolic syndrome could heighten the burden of oxidative stress (i.e. oxidized low-density lipoprotein) and inflammation (i.e. CRP) in obese adults, 7 while another study reported that metabolic syndrome was significantly associated with the level of CRP but not with oxidative stressrelated markers (i.e. F 2 -isoprostane). 8 This paucity of clinical studies is partially due to the limited indices available to analyse easily the oxidative stress status in patients during daily clinical practice. 9 The test for diacron reactive oxygen metabolites (d-ROMs), which can quantify oxidative stress status by measuring the levels of hydroperoxides of global organic compounds (lipids, proteins, nucleic acids, etc.) has been introduced fairly recently as a simple clinical marker for oxidative stress. 10 -12 In fact, there have been several studies demonstrating a significant positive relationship between d-ROMs and hs-CRP levels in patients at high-risk for CVD 13 as well as in the general population. 14 -16 To date, there have been no comparative studies on the association between the d-ROMs and hs-CRP levels in subjects with and without metabolic syndrome. The present study, therefore, investigated the association and the differences in d-ROMs and hs-CRP levels between subjects with and without metabolic syndrome.
Subjects and methods

STUDY POPULATION
This cross-sectional observational study sequentially recruited women undergoing routine health check-ups in health education classes and outpatient clinics (primary care settings) in the Kansai and Chugoku-Shikoku regions of Japan between 2006 and 2011. The study population was divided into subjects diagnosed as having metabolic syndrome and those without. Subjects with three of the following five cardiometabolic risk factors were diagnosed with metabolic syndrome according to the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP) III recommendations: 1 (i) obesity identified by a body mass index (BMI) ≥ 25.0 kg/m 2 , as specifically intended for a Japanese population; 17 (ii) high systolic blood pressure (SBP), defined as ≥ 130 mmHg and/or high diastolic blood pressure (DBP), defined as ≥ 85 mmHg; (iii) hypertriglyceridaemia, defined as serum triglyceride (TG) concentration ≥ 1.69 mmol/l; (iv) low highdensity lipoprotein cholesterol (HDL-C) level, defined as serum HDL-C < 1.29 mmol/l; and (v) hyperglycaemia, defined as fasting plasma glucose (FPG) concentration ≥ 6.1 mmol/l. Inclusion criteria were that the subjects were nonsmokers and not taking any medication or supplements. Exclusion criteria were acute infections, such as a common cold, or history of cardio/cerebrovascular, thyroid, collagen, severe kidney or liver diseases.
The study was approved by the Ethics Committee of the National Hospital Organization Kyoto Medical Centre (No. 04-09, 08-38, 11-41), and all subjects provided written informed consent to participate in the study.
CLINICAL AND LABORATORY PARAMETERS
Measurement of SBP and DBP was undertaken in the right arm using a mercury K Kotani, N Sakane C-reactive protein and d-ROMs in metabolic syndrome sphygmomanometer with the subject in the seated position. Venous blood (approximately 5 ml) was collected at recruitment from the antecubital vein after an overnight fast into tubes containing 2% ethylenediaminetetra-acetic acid for plasma separation, or tubes without anticoagulant for serum separation. Serum total cholesterol (TC), TG, HDL-C and FPG levels were measured enzymatically (reagents: Kyowa Medecs, Tokyo, Japan; automatic analyser: 7600 model, Hitachi, Tokyo, Japan). Serum samples for analysis of hs-CRP and d-ROMs were prepared and frozen at -80°C until measurement. The level of serum hs-CRP was measured by enzyme-linked immunosorbent assay (Assaypro, St Charles, MO, USA). Levels of d-ROMs were obtained using a kinetic spectrophotometric assay (F.R.E.E system; Diacron, Grosseto, Italy) with intraand interassay coefficients of variation of 2.1% and 3.1%, respectively. 11, 12 Briefly, serum samples were mixed with a 50 mmol sodium acetate buffered solution, pH 4.8, and a chromogenic substrate (N,N-diethyl-pphenylenediamine, included as R1-reagent in the F.R.E.E. system d-ROMs test kit), as described previously. 10 The mixture was then incubated in a thermostatic block at 37°C for 3 min. Absorbance was measured at a wavelength of 505 nm and expressed in Carratelli units (U Carr).
STATISTICAL ANALYSES
The mean ± SD or median and interquartile range data were calculated and statistical analyses were carried out using the SPSS ® statistical package, version 16.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Differences between the groups were compared using an unpaired t-test. A simple correlation test (Pearson's correlation coefficient) and a multiple linear regression analysis, adjusted for all the cardiometabolic risk factors, were used to assess the correlation between the d-ROMs and hs-CRP levels in the two study groups. The between-group correlation level was compared by the Z-transformation test of the correlation coefficients. Because of the close correlation between SBP and DBP, only SBP was entered into the multiple linear regression analysis model. The TG and hs-CRP values were log-transformed in these analyses because of their skewed distributions. Statistical significance was defined as P < 0.05.
Results
The study included a total of 457 women: 123 diagnosed with metabolic syndrome and 334 without metabolic syndrome. Their demographic and clinical characteristics are shown in Table 1 . The group with metabolic syndrome had significantly higher BMI, SBP, DBP, TG and FPG as well as a significantly lower HDL-C than the group without metabolic syndrome (P < 0.01 for all comparisons; Table 1 ). The group with metabolic syndrome showed significantly higher levels of d-ROMs (P < 0.01) and hs-CRP (P < 0.01) than the group without metabolic syndrome. Table 2 shows the correlation between d-ROMs (as a dependent variable) and hs-CRP and various clinical and cardiometabolic risk factors. Simple correlation analysis showed that the d-ROMs level was significantly and positively correlated with the hs-CRP level in the group without and in the group with metabolic syndrome (P < 0.01 for both). Additionally, the correlation level between the two groups was significantly different (P < 0.05). Multiple linear regression analysis revealed that the d-ROMs level remained independently, significantly and positively correlated with the hs-CRP level in the group with metabolic syndrome (P < 0.01) and also in the group without K Kotani, N Sakane C-reactive protein and d-ROMs in metabolic syndrome metabolic syndrome (P < 0.05). While simple correlation analysis showed that the d-ROMs level was significantly and positively correlated with age (P < 0.05) and the BMI level (P < 0.05), and significantly and inversely correlated with the HDL-C level (P < 0.05) in the group without metabolic syndrome, subsequent multiple linear 
TABLE 2: Correlation of diacron reactive oxygen metabolites as a dependent variable with highsensitivity C-reactive protein (hs-CRP) and the various clinical and cardiometabolic risk factors, according to whether or not the subjects had metabolic syndrome
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regression analysis revealed that the correlations were no longer significant in this group. Simple correlation analysis and multiple linear regression analysis revealed that the d-ROMs level was independently, significantly and positively correlated with the FPG level in the group with metabolic syndrome (P < 0.01). Table 3 shows the correlation between hs-CRP (as a dependent variable) and d-ROMs and various clinical and cardiometabolic risk factors. Simple correlation analysis and multiple linear regression analysis both showed similar results in terms of the correlations between hs-CRP and d-ROMs to those found with d-ROMs as a dependent variable and shown in Table 2 . Simple correlation analysis also showed that the hs-CRP level was significantly and positively correlated with age, BMI and SBP (all P < 0.01). Simple correlation analysis showed significant and inverse correlations with TC (P < 0.05) and HDL-C levels (P < 0.01) in the group without metabolic syndrome. Subsequent multiple linear regression analysis revealed that hs-CRP remained independently, significantly and positively correlated with BMI, and independently, significantly and inversely correlated with the HDL-C level in the group without metabolic syndrome (P < 0.01 for both). Simple correlation analysis and multiple linear regression analysis revealed no significant correlations between hs-CRP level and other cardiometabolic risk factors in the group with metabolic syndrome.
Discussion
The present study showed a greater correlation between d-ROMs and hs-CRP in subjects with metabolic syndrome compared with those without, suggesting a closer relationship between inflammation and oxidative stress in subjects with metabolic syndrome than in those without. This coexistence may partially explain the higher CVD risk in patients with metabolic syndrome. 1, 2 
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Although the correlation between inflammation and oxidative stress seems to be consistent with an earlier study, 7 it is worth noting that the present study used a more recently identified oxidative stressrelated marker (d-ROMs) than the previous study. In addition, while the significant and positive correlation between d-ROMs and hs-CRP levels has been previously reported in patients at high-risk for CVD 13 and in general populations, 14 -16 the present study adds valuable data specifically focused on a comparison of subjects with versus those without metabolic syndrome.
The precise biological mechanisms underlying the results obtained in the present study are unclear, although there are several plausible explanations. Oxidative stress, which stems from an imbalance in oxidation/redox systems (e.g. caused by an unhealthy lifestyle) and inflammation can induce further oxidative stress and inflammatory molecules via cell dysfunction in various organs (e.g. adipose tissue and liver) and insulin resistance. 4, 18 In particular, the adipocytes in accumulated fat tissues promote systemic oxidative stress via increased production of nicotinamide adenine dinucleotide phosphate oxidase and a decrease in antioxidative molecules, 18, 19 as well as inflammation via macrophage-related adipokines. 20, 21 Such oxidative stress and inflammation are associated with vascular dysfunction. 16, 22, 23 In fact, oxidative stressrelated molecules 24, 25 and inflammatory molecules such as CRP 24 are present in atherosclerotic lesions. In the vasculature, oxidative stress induces inflammation, 5 and inflammatory molecules such as CRP also stimulate the generation of reactive oxygen species. 26, 27 These pathways generate a vicious cycle of oxidative stress and inflammation. 5 Enhancement of this cycle in subjects with metabolic syndrome, as characterized by fat accumulation and vascular dysfunction, may account, at least partially, for the closer correlation between oxidative stress and inflammation observed in the present study in subjects with metabolic syndrome compared with those without.
The present study also showed a significant and positive correlation between levels of d-ROMs and FPG in the group with metabolic syndrome, as well as a significant and positive correlation between the hs-CRP level and BMI and a significant and inverse correlation between the hs-CRP and HDL-C levels in the group without metabolic syndrome. These findings appear to be consistent with earlier studies. 28, 29 This pattern may be due, in part, to differences in the cardiometabolic risk factors between the two groups and/or metabolic changes specifically found in metabolic syndrome patients (i.e. obesity and its related cytokine/hormone levels). 28, 29 There were some limitations to the present study. The cross-sectional nature of the study design limited the evaluation of causal relationships among oxidative stress, inflammation and metabolic syndrome. Additionally, data on CVD-related outcomes were not available. Future studies with a prospective design and data on CVD-related outcomes will be necessary to confirm these findings.
In summary, the present study showed that there was a greater correlation between the levels of d-ROMs and hs-CRP in subjects with metabolic syndrome compared with those without. This suggests that subjects with metabolic syndrome may have a closer relationship between inflammation and oxidative stress than those without metabolic syndrome, possibly reflecting their • Received for publication 27 January 2012 • Accepted subject to revision 10 February 2012
• Revised accepted 3 April 2012 Copyright © 2012 Field House Publishing LLP increased predisposition to atherosclerosis. Further studies are required to confirm this relationship.
